These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 14977391

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR, Faulds D.
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L.
    Am J Clin Dermatol; 2007 Feb; 8(5):271-83. PubMed ID: 17902729
    [Abstract] [Full Text] [Related]

  • 26. Comparison of efficacy, safety, and skin test inhibition of cetirizine and astemizole.
    Berkowitz RB, Dockhorn R, Lockey R, Findlay S, Howland WC, Mitchell DQ, Woehler T.
    Ann Allergy Asthma Immunol; 1996 Apr; 76(4):363-8. PubMed ID: 8612120
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition of histamine or allergen-induced wheals by a single dose of acrivastine, fexofenadine or cetirizine.
    Ballmer-Weber BK, Gex-Collet C, Wüthrich B.
    J Investig Allergol Clin Immunol; 1999 Apr; 9(6):351-5. PubMed ID: 10664928
    [Abstract] [Full Text] [Related]

  • 32. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis.
    Howarth PH, Stern MA, Roi L, Reynolds R, Bousquet J.
    J Allergy Clin Immunol; 1999 Nov; 104(5):927-33. PubMed ID: 10550734
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Loratadine versus cetirizine: assessment of somnolence and motivation during the workday.
    Salmun LM, Gates D, Scharf M, Greiding L, Ramon F, Heithoff K.
    Clin Ther; 2000 May; 22(5):573-82. PubMed ID: 10868555
    [Abstract] [Full Text] [Related]

  • 35. Desloratadine: an update of its efficacy in the management of allergic disorders.
    Murdoch D, Goa KL, Keam SJ.
    Drugs; 2003 May; 63(19):2051-77. PubMed ID: 12962522
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers.
    Frossard N, Benabdesselam O, Purohit A, Mounedji N, Pauli G.
    Fundam Clin Pharmacol; 2000 May; 14(4):409-13. PubMed ID: 11030449
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Rapid symptom relief in rhinitis.
    Bousquet J.
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():25-9. PubMed ID: 10209702
    [Abstract] [Full Text] [Related]

  • 40. Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
    Izumi N, Mizuguchi H, Umehara H, Ogino S, Fukui H.
    Methods Find Exp Clin Pharmacol; 2008 Apr; 30(3):225-30. PubMed ID: 18597008
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.